News

Japan’s presidency of the G20 2019 has come to an end.

A new global multi-stakeholder partnership being launched is a promising – and necessary – step forward in the global effort to effectively combat Alzheimer’s disease and dementia.

At the beginning of the last decade, in the summer of 2010, the trial for Semagacestat was canned. It was the story of the decade. There are good reasons to hope that it will not be the story of this decade. We are making progress.